Zogenix Inc (ZGNX)

12.85
0.10 0.78
NASDAQ : Health Care
Prev Close 12.75
Open 12.80
Day Low/High 12.55 / 13.00
52 Wk Low/High 7.33 / 21.03
Volume 137.84K
Avg Volume 205.70K
Exchange NASDAQ
Shares Outstanding 24.81M
Market Cap 325.06M
EPS -2.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Zogenix Completes Enrollment In First ZX008 Phase 3 Clinical Trial In Dravet Syndrome

Zogenix Completes Enrollment In First ZX008 Phase 3 Clinical Trial In Dravet Syndrome

Study 1 Top-Line Data on Track for 3Q 2017

August 18th Options Now Available For Zogenix (ZGNX)

August 18th Options Now Available For Zogenix (ZGNX)

Investors in Zogenix Inc. saw new options become available today, for the August 18th expiration.

Biotech Premarket Movers: ChemoCentryx, Jazz, Ionis, Zogenix

Biotech Premarket Movers: ChemoCentryx, Jazz, Ionis, Zogenix

ChemoCentryx, Jazz Pharmaceuticals, Ionis Pharmaceuticals and Zogenix were among the biotech stock movers in premarket trading Friday.

Notable Friday Option Activity: ZGNX, EPM, STZ

Notable Friday Option Activity: ZGNX, EPM, STZ

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Zogenix Inc. , where a total of 1,940 contracts have traded so far, representing approximately 194,000 underlying shares.

These 5 Stocks Under $10 Could Light Up Soon

These 5 Stocks Under $10 Could Light Up Soon

Here's a technical look at how to trade several under $10 stocks that could trigger big breakout trades soon.

Zogenix Announces Issuance Of U.S. Patent For ZX008 In Dravet Syndrome

Zogenix Announces Issuance Of U.S. Patent For ZX008 In Dravet Syndrome

Issued Patent is First Covering Company's Treatment of Seizures Associated with Dravet Syndrome Using Fenfluramine as an Adjunctive Therapy

Zogenix Announces CFO Transition

Zogenix Announces CFO Transition

Ann D. Rhoads to Depart Company Following Transition Period; Biopharmaceutical Industry Veteran Michael P. Smith Appointed New CFO

17 Thoughts on Biotech Stocks to Kick Off 2017

17 Thoughts on Biotech Stocks to Kick Off 2017

Adam Feuerstein compiles a list of questions, thoughts, declarations, catalysts and observations about biotech stocks to help investors prepare for the year ahead.

Depomed Reports Dip in Earnings, Reduces Revenue Guidance

Depomed Reports Dip in Earnings, Reduces Revenue Guidance

Despite a win in court over its patents and a deal with activist investors, Depomed shares dropped after it gave a reduced guidance for 2016 revenues.

Zogenix Provides Corporate Update And Reports Third Quarter 2016 Financial Results

Zogenix Provides Corporate Update And Reports Third Quarter 2016 Financial Results

Company will host a conference call today at 4:30 p.m. EST/1:30 p.m. PST

Humana, Pharma Stocks Sink as Healthcare is Worst Performing Sector Wednesday

Humana, Pharma Stocks Sink as Healthcare is Worst Performing Sector Wednesday

Shares of Omeros fell almost 10% after analysts' downgraded the biotech.

Zogenix To Have Significant Presence At 12th European Congress On Epileptology

Zogenix To Have Significant Presence At 12th European Congress On Epileptology

Company's Four Poster Presentations to Focus on ZX008 Open-Label Cohort and Burden of Dravet Syndrome

Zogenix Provides Corporate Update And Reports Second Quarter 2016 Financial Results

Zogenix Provides Corporate Update And Reports Second Quarter 2016 Financial Results

Company will host a conference call today at 4:30 p.m. EDT/1:30 p.m. PDT